IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
In Memoriam: Dr. Chris Scanlan, our colleague and friend at the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, 1977-2013 May 2013
VOICE Trial Results Underscore Need to Accelerate Development of Additional HIV Prevention Options for Women March 2013 AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity November 2012 CAPRISA: Study discovers a unique feature of HIV that enables infected people to make antibodies able to kill a wide range of human immunodeficiency viruses October 22, 2012 HIV Vaccines and Microbicides Resource Tracking Working Group report calls for sustained funding of HIV prevention research July 23, 2012 AIDS 2012 Conference Plenary—Ending the Epidemic: Turning the Tide Together July 23, 2012 NIH Awards $31 Million for HIV/AIDS Vaccine Immunology and Immunogen Discovery July 11, 2012 Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV April 4, 2012 GHTC 2012 Policy Report February 28, 2012
Sign up for our e-mail newsletter.